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Abstract
The mechanisms by which environmental toxicants alter developmental processes predisposing individuals to adult onset
chronic disease are not well-understood. Transplacental arsenic exposure promotes atherogenesis in apolipoprotein E-
knockout (ApoE
2/2) mice. Because the liver plays a central role in atherosclerosis, diabetes and metabolic syndrome, we
hypothesized that accelerated atherosclerosis may be linked to altered hepatic development. This hypothesis was tested
in ApoE
2/2 mice exposed to 49 ppm arsenic in utero from gestational day (GD) 8 to term. GD18 hepatic arsenic was
1.2 mg/g in dams and 350 ng/g in fetuses. The hepatic transcriptome was evaluated by microarray analysis to assess
mRNA and microRNA abundance in control and exposed pups at postnatal day (PND) 1 and PND70. Arsenic exposure
altered postnatal developmental trajectory of mRNA and microRNA profiles. We identified an arsenic exposure related 51-
gene signature at PND1 and PND70 with several hubs of interaction (Hspa8, IgM and Hnf4a). Gene ontology (GO)
annotation analyses indicated that pathways for gluconeogenesis and glycolysis were suppressed in exposed pups at
PND1, and pathways for protein export, ribosome, antigen processing and presentation, and complement and
coagulation cascades were induced by PND70. Promoter analysis of differentially-expressed transcripts identified enriched
transcription factor binding sites and clustering to common regulatory sites. SREBP1 binding sites were identified in
about 16% of PND70 differentially-expressed genes. Western blot analysis confirmed changes in the liver at PND70 that
included increases of heat shock protein 70 (Hspa8) and active SREBP1. Plasma AST and ALT levels were increased at
PND70. These results suggest that transplacental arsenic exposure alters developmental programming in fetal liver,
leading to an enduring stress and proinflammatory response postnatally that may contribute to early onset of
atherosclerosis. Genes containing SREBP1 binding sites also suggest pathways for diabetes mellitus and rheumatoid
arthritis, both diseases that contribute to increased cardiovascular disease in humans.
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Introduction
Environmental exposures during embryonic/fetal development
have been shown to disturb the embryonic/fetal developmental
program [1]. Some exposures cause severe disturbance of the
program and result in gross structural anomalies. Others may have
more subtle effects and may contribute to increased susceptibility
to chronic adult diseases including cancer, diabetes and cardio-
vascular disease (CVD). The mechanism(s) underlying the effects
of more modest environmental exposures on outcomes decades
later are not understood.
The major cause of death in the U.S. is CVD. Atherosclerosis
underlies most CVD which most often culminates in myocardial
infarctions, strokes and renal disease. Inorganic arsenic (As) is a
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38713worldwide natural drinking water contaminant [2,3] affecting over
140 million people in over 70 countries and is a high priority
hazardous substance in the United States. Drinking water arsenic
in third world countries is often above 100 mg/L and can be over
1 mg/L as in parts of West Bengal [4]. These high level exposures
also occur in unregulated private well water in rural areas of the
United States. In humans, arsenic exposure causes cancer,
diabetes and atherosclerosis [2,3,5–7]. Arsenic can be teratogenic
in rodents [8]. Epidemiological studies indicate that chronic
arsenic ingestion causes CVD in humans (reviewed in [7]). A
recent study showed that even very low arsenic exposure is
associated with elevated CVD in Spain [9]. A West Bengali
population with arsenic exposure had high rates of non-cirrhotic
portal hypertension [10] which is consistent with recent findings of
loss of hepatic sinusoidal fenestrae in arsenic exposed mice [11]. A
recent longitudinal study found that the leading cause of death in
arsenic exposed region of Bangladesh was CVD [12]. The
incidence of CVD is increased in the U.S. when the drinking
water As concentration exceeds 5 ppb [5,6,13,14]. Thus, wide-
spread exposure to arsenic in drinking water in the U.S. likely
contributes to atherogenesis and death from CVD. Early life,
particularly fetal, arsenic exposure contributes to development of
CVD in adult life. Deaths from myocardial infarction caused by
advanced arteriosclerosis of infants whose mothers consumed
water with very high levels of arsenic clearly indicate that
transplacental arsenic exposure is a risk factor for arterial disease
in humans [15,16]. Thus, it is clear that arsenic exposure
contributes to CVD in adulthood, but the mechanism of arsenic-
induced arterial disease is not known.
The interaction of in utero arsenic exposure with disease
predisposition is not well understood. A transplacental arsenic
exposure model of cancer induction in mice has been character-
ized and showed decreased latency and increased multiplicity of
tumors in cancer prone C3H mice [17]. Whole life exposures
(beginning preconception) induce tumors in CD1 mice which have
a very low cancer background [18]. The studies to date in this
model indicate that arsenic exposure alters gene expression in
target tissues [19] and increases the stem cell population [20]. We
developed an analogous model for in utero arsenic exposure
induction of CVD. Our studies demonstrated that atherosclerosis
in Apolipoprotein E-knockout (ApoE
2/2) mice is both accelerated
and exacerbated by transplacental arsenic exposure from gesta-
tional day 8 to birth [21]. In utero arsenic exposure reduced the
time to detectable atherosclerotic disease to 10 weeks of age. Thus,
the disease outcome of in utero arsenic exposure appears to be
dependent upon the genetic predisposition to disease [22].
The liver plays a central role in the interlinked diseases diabetes
mellitus, metabolic syndrome and atherosclerosis. Atherosclerotic
changes in arsenic exposed ApoE-knockout mice are associated
with decreases in plasma triglycerides [21–23]. The liver is the
principal site of plasma triglyceride synthesis. Arsenic is a well
known hepatotoxicant and causes fatty liver disease that can
progress to cirrhosis. Arsenic exposure-induced liver disease is one
example of environmental exposures leading to what has been
termed toxicant associated steatohepatitis (TASH) [24]. Fatty liver
disease is an independent risk factor for CVD (reviewed in
[25,26]). Thus, we reasoned that arsenic-induced liver disease is a
likely cause of the accelerated atherogenesis we observe in ApoE
2/
2 mice. Furthermore, we hypothesized that transplacental arsenic
exposure impacted liver development and that in utero arsenic
exposure serves as the first hit in a two-hit model of liver injury
that ultimately contributes to accelerated atherogenesis in arsenic
exposed mice.
Hence, we sought to determine whether changes in gene
expression could be detected that would correspond to altered
development in livers of arsenic exposed mice. We show that
changes in developmental trajectory are reflected in alterations in
mRNA and microRNA expression patterns. These transplacental
arsenic exposure induced liver gene expression changes also are
linked to systemic inflammatory diseases associated with increased
CVD in humans. Predictions from the transcriptomics data and
their analyses are substantiated by biochemical and biological data
suggesting long lasting stress response and subtle liver injury
contributing to a pro-inflammatory state in the livers of exposed
mice.
Results
Arsenic Exposure Model is Relevant to Human
Populations with High Arsenic Exposure
Phenotypic anchoring of the arsenic exposure model is
important for relevance to human exposures. Drinking water
arsenic exposures in West Bengal and other third world countries
can be as high as 1 ppm (or even higher). The mean adult liver
arsenic content in a sample of the arsenic exposed Bengali
population was reported to be ,1.5 mg/kg [10]. We measured
arsenic levels in livers from exposed and unexposed pregnant dams
and their fetuses at GD18. As shown in Figure 1, maternal arsenic
exposure increased arsenic content in liver ,55-fold to ,1.2 mg/g
wet weight, similar to that reported in the Bengali sample, and in
the fetuses ,26-fold to ,350 ng/g. Thus, our animal model
displays a key tissue phenotype that is consistent with human
populations with high arsenic exposures. In addition, these results
indicate that arsenic absorbed by the mother was crossing the
placenta and getting to the fetal livers.
mRNA and microRNA Expression Analyses
The expression of most genes in a pathway changes little when a
pathway is induced because only a few are actually rate limiting.
However, in order to identify an affected pathway in biological
function analyses, one must have a sufficient number of genes
differentially expressed to detect an enriched pathway. In addition,
we were analyzing total liver RNA and liver is composed of
Figure 1. Determination of As levels in livers of pregnant dams
and GD18 fetuses after 10 days exposure to 49 ppm As (as
NaAsO2) in drinking water. Means6SD. P,0.01.
doi:10.1371/journal.pone.0038713.g001
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RNA pool. Our plan included confirmation of conclusions from
genomics analyses with biochemical or biological assays post-hoc.
Hence, we sought to identify all genes with changed expression
and set the criteria accordingly. Total RNAs were prepared from
liver samples from pups prenatally exposed to arsenic and
evaluated on day of birth (PND1) and 10-weeks of age (PND70)
(n=3 for each group). The experimental design and workflow for
the RNA analyses is shown in Figure 2. RNAs were prepared and
analyzed by microarrays as described in methods. We identified a
total 848 probes mapping to 797 individual genes with expression
changed by in utero arsenic exposure at PND1 and 763 probes
mapping to 712 individual genes at PND70 (p,0.01, any change;
Figure 3A).
Arsenic Exposure Differential Gene Expression Signature
We next sought to identify a postnatal signature modified by
prenatal arsenic exposure. Comparative analysis of differentially-
expressed mRNAs at PND1 and PND70 revealed a 51 gene
signature with significantly altered expression at both life stages
(Figure 3A). Unsupervised cluster analysis further classified these
genes into four major groups. Some genes had increased
expression at both time points, some were decreased at both time
points, some were up at one and down at the other time point
(Figure 3B).
Principal component analysis of the 51-gene signature set
showed the major explained variance was due to life stage. This
was followed by treatment (Figure 3C). However, the postnatal
developmental trajectories were markedly different in arsenic
exposed and unexposed animals. This implies a shift in fetal
programming due directly or indirectly to the maternal arsenic
intake.
Analysis with Pathway Architect (Figure 3D) identified three
major hubs in the interactome of the 51 gene signature (Table 1):
HspA8, IgM and HNF4A. Hspa8 is heat shock 70 kDa protein 8,
a cognate heat shock protein, and its mRNA was induced at both
PND1 and PND70. In contrast, IgM, the immunoglobulin light
chain variable region, is suppressed at both PND1 and PND70.
HNF4A is a hub, but its mRNA was unchanged. However,
HNF4A is known to regulate LEF1, GSTA4, CDCA5, CYP7A1
and UGDH which were induced or suppressed by prenatal arsenic
exposure (Table 1).
Differential Gene Expression Analyses Suggest Activation
of Inflammatory Pathways
Interactome analyses of the entire sets of differentially expressed
mRNAs at PND1 (Figure 4A) and PND70 (Figure 4B) revealed the
HNF4A hub, along with elevation of a variety of inflammatory
cytokines. HNF4A also is a major hub in the interactome of
mRNAs suppressed at PND70 (Figure S1). The network linkages
to HNF4A in the PND70 interactome are genes not traditionally
associated with inflammation. HspA8 (HSC70) and HspA1B
(HSP70) were major hubs in the PND70 interactome. Thus, the
51-gene signature identified major hubs present in the individual
interactomes at each age. Tnf, a multifunctional proinflammatory
cytokine secreted mainly by macrophages, was a major hub in
both the PND1 and PND70 total interactomes (Figure 4). Tnf was
unchanged in PND1 but induced in PND70 livers, and was a
major hub in the interactome of genes induced in livers of arsenic
exposed PND70 mice with links to several induced inflammatory
cytokines (Figure S2). These results are consistent with a pro-
inflammatory state at PND70.
MicroRNAs (miRNAs) are believed to play a role in develop-
mental buffering and pathway regulation. We thus profiled the
miRNA transcriptome to determine if developmental alterations
would be reflected in the liver at PND1 and PND70. We identified
31 annotated microRNAs differentially expressed at either time
point by arsenic exposure. The mRNA targets of these micro-
RNAs were queried from the Sanger miRbase database. Three
miRNAs were induced and eight were suppressed in livers of
arsenic exposed PND1 mice (Table 2). Scanning the miRBase with
three induced miRNAs resulted in 2413 non-redundant targets
(2813 redundant targets) whereas scanning with the eight
suppressed microRNAs resulted in 4994 non-redundant targets
(6780 non-redundant). There were 1038 common probes between
targets of three induced and eight suppressed PND1 microRNAs.
Five microRNAs were induced and 15 were suppressed (Table 2)
in livers of arsenic exposed PND70 mice. Scanning miRBase for
target mRNAs with the five induced microRNAs resulted in 2669
non-redundant targets (3579 redundant targets) whereas 15
suppressed microRNAs had 8246 non-redundant targets (13142
non-redundant). There were 1856 common probes between
targets of five induced and 15 suppressed PND70 microRNAs.
There was no uniform correlation in differential expression
between the targets for these microRNAs and differentially
expressed mRNAs. We did see both induction and suppression
of the target mRNA transcripts.
Developmental miRNA expression does not necessarily have
an inverse correlation with target gene expression. Both
coherent and non-coherent expression is found in developmental
systems [27,28]. Hence it was not surprising that we did not
find an inverse correlation between mRNAs identified by the
Figure 2. Diagram of experimental design and analytical flow
for mRNA and miRNA data.
doi:10.1371/journal.pone.0038713.g002
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target mRNAs of the differentially expressed microRNAs. GO
annotation analysis of the differentially-expressed miRNA
targeted mRNAs were analyzed by DAVID to identify which
pathways were represented among the set. The results indicate
that fundamental metabolic processes (glycolysis/gluconeogene-
Figure 3. Identification and analyses of 51 genes differentially expressed at both PND1 and PND70. A. Intersection of genes
differentially expressed at PND1 and PND70. B. Hierarchical clustering of 51 genes differentially expressed at both PND 1 and PND70. C. Principal
component analysis of 51 genes differentially expressed at both PND 1 and PND70. (Arrows added for clarity) D. Pathway Architect analysis of 51
genes differentially expressed at both PND 1 and PND70.
doi:10.1371/journal.pone.0038713.g003
Table 1. Network analysis of 51 gene signature.
Gene Description Change in expression
PND1 As PND70 As
Hspa8 Cognate HSP70 Up Up
Igm Immunoglobulin light chain variable region Down Down
Hnfa controls liver expression of several genes including the following: NC NC
Lef1 lymphoid enhancer-binding factor 1 Up Down
Aqp1 water channel Up Down
Gsta4 glutathione S-transferase A4 Down Up
Cdca5 regulator of sister chromatid cohesion Down Up
Cyp7a1 rate limiting step and the major site of regulation of bile acid synthesis Down Up
Ugdh biosynthesis of glycosaminoglycans Down Up
NC=not changed.
doi:10.1371/journal.pone.0038713.t001
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that protein metabolism (protein export, ribosome) and inflam-
matory processes (complement, antigen processing, coagulation)
were increased in livers of arsenic-exposed PND70 mice
(Table 3). These pathways also are represented in the GO
analyses of total mRNAs induced or suppressed at PND1 or
PND70 (Tables S1, S2, S3, S4).
Identification of Common Transcription
Factors Potentially Regulating the Changes in Expression
Profiles
We searched for potentially coordinately regulated sets of genes
by performing transcription factor binding site (TFBS) analysis of
the differentially expressed genes. The sequences of the regions
2k b5 9 plus 200 bp 39 to the transcription initiation site of each
gene were collected from Genbank. These sequences were
submitted to the Transfac database [29] to identify TFBS and
then analyzed using Expander to identify TFBS enrichment
(Tables S5, S6, S7, S8, S9, S10, S11, S12). A total of 760 unique
Entrez gene IDs were differentially expressed mRNAs at PND1
and a total 18 TFBS were enriched in this gene set (P,0.05).
Likewise, a total of 690 unique Entrez gene IDs were differentially
expressed mRNAs at PND70, and a total 31 TFBS were enriched
in this gene set (P,0.05). Among the enriched TFBS identified are
several that are particularly pertinent to this discussion. These
include the developmental regulatory factor homeobox C8
(HOX3A), stress response factors heat shock factor (HSF), nuclear
factor of kappa light polypeptide gene enhancer in B-cells 1
(NFKB) and activator protein 1 (AP1), environmental agent
response factors arylhydocarbon receptor (AHR) and hypoxia
inducible factor (HIF1), cell cycle regulatory factor E2F transcrip-
tion factor 1 (E2F1), the lipid metabolism regulator gene sterol
regulatory element binding protein 1 (SREBP1), and chromatin
remodeling factor p300 among others (Tables 4 and 5, and S5, S6,
S7, S8, S9).
Table 5 lists the differentially-expressed genes at each life stage
that also were targets of differentially-expressed miRNAs at that
age and that contained the enriched TFBS present in their
promoters. Assuming genes with shared multiple TFBS are
coordinately regulated, we noted (Figure 5) the upper left of the
PND70 map showing 7 genes (Osgep, Armet, Cdca5, Cdkn2d, Kpnb1,
Sec23b) sharing 4 TFBS (E2F1, ETF, Ap2, NFY). In addition, 113
genes with altered expression at PND70 had binding site(s) for
SREBP1 (Table 4). SREBP1 target genes were not, however,
represented among the differentially-expressed miRNAs. The
large fraction of the genes with altered expression, all with a
common TFBS, thus suggests that SREBP1 is activated and
perhaps coordinately regulates this network of genes.
Figure 4. Interactome maps of differentially expressed mRNAs in livers of arsenic-exposed mice. A. PND1; B. PND70. Major hubs are
annotated.
doi:10.1371/journal.pone.0038713.g004
Table 2. microRNAs differentially expressed at PND1 and
PND70.
microRNAs induced
at PND1
microRNAs induced
at PND70
mmu-miR-361 mmu-miR-211
mmu-miR-148a mmu-miR-291a-5p-291b-5p
mmu-miR-467a mmu-miR-294
mmu-miR-302
mmu-miR-464
microRNAs suppressed
at PND1
microRNAs suppressed
at PND70
mmu-miR-188 mmu-miR-1
mmu-miR-211 mmu-miR-10a
mmu-miR-222 mmu-miR-15b
mmu-miR-497 mmu-miR-124a
mmu-miR-592 mmu-miR-130a
mmu-miR-679 mmu-miR-149
mmu-miR-719 mmu-miR-184
mmu-let-7d mmu-miR-193
mmu-miR-218
mmu-miR-337
mmu-miR-376a
mmu-miR-412
mmu-miR-467b
mmu-miR-681
mmu-miR-715
doi:10.1371/journal.pone.0038713.t002
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Expression in Adult Livers that Confirm Inferences from
the mRNA Abundance and TFBS Analyses
The mRNA expression data indicated that the genes for heat
shock 70 proteins, HSP70 (HSPA1B, inducible form) and HSC70
(HSPA8, constitutive form), were induced. TFBS analyses
indicated that SREBP1 binding sites were enriched in the
promoters of differentially expressed genes in PND70 mice
suggesting potential coordinate induction by SREBP1. However,
SREBP1 mRNA level was unchanged. Because, SREBP1 activity
is dependent upon cleavage in the endoplasmic reticulum, we
examined expression of HSP70, HSC70 and the active form of
SREBP1 by western blot analysis. The data (Figure 6) indicate that
levels of HSP70 and activated SREBP1 are elevated in livers of As-
exposed mice. Thus, the prediction made from the TFBS analysis,
that activated SREBP1 is likely elevated because a battery of
differentially expressed genes have an SREBP1 binding site in
their promoters, is confirmed at the protein level. HSC70 did not
change with arsenic exposure (not shown). The induction of
HSP70 and activated SREBP1 in PND70 mice suggests a mild
stress following prenatal arsenic exposure enduring into adult life.
These results support the inferences made from the bioinformatics
analyses of the mRNA microarray data.
Disease Functions Identified in Srepb1 TFBS Containing
Gene Set
The induction of activated SREBP1 in the face of unchanged
SREBP1 mRNA and reduced plasma triglycerides implies a
dysregulation of lipid metabolism and/or transport. The 113
genes with SREBP1 TFBS were analyzed for interaction
networks and disease functions using IPA software. The results
revealed that this set of genes contained subnetworks of genes
associated with immunological disorder, autoimmune disease,
rheumatoid arthritis and insulin dependent diabetes mellitus
(Figure 7). These subsets of genes overlap with one another
consistent with the obvious relatedness of the first three subsets.
Induction of these gene sets also is consistent with a pro-
inflammatory state.
Subtle Liver Injury Persists Long After Arsenic Exposure
The microarray data suggested that inflammatory cytokines
were elevated in livers of newborn (PND1) mice and that the stress
response was activated in PND70 livers. In particular, tumor
necrosis factor alpha (TNFA) expression was elevated in PND70
mice and TNFA has been linked to liver inflammation [30].
Therefore, we examined the livers of arsenic exposed and
unexposed mice at 10 weeks of age to determine whether signs
of inflammation were present. Histological assessment of liver
tissues stained with hematoxylin and eosin revealed no macro-
scopic histological changes in the livers of arsenic-exposed mice
(not shown). However, liver injury may be subtle. Therefore, we
determined levels of circulating liver enzymes as clinical markers of
liver injury. Plasma levels of both ALT and AST determined using
commercially available kits were elevated in arsenic-exposed mice
suggesting liver damage (Figure 8). These results support the gene
expression data suggesting elevated liver inflammation and clearly
indicate that prenatal arsenic exposure causes subtle (but
significant) liver damage that may prime the liver for an
inflammatory stimulus.
Discussion
In the current study, we used a transcriptomics approach to
investigate dysregulation of liver development induced by prenatal
arsenic exposure in ApoE-knockout mice. Differential gene
expression at birth (immediately after the exposure) and at age
10 weeks (when accelerated atherogenesis is first detectable [21])
showed that the liver developmental program was dysregulated. A
51-gene expression signature of arsenic-induced developmental
changes was identified. Increased expression of inflammatory
cytokine and heat shock protein 70 (HSP70) mRNAs in livers of 10
week old mice suggested an enduring state of stress and the
presence of subtle liver injury. Promoter analyses for TFBS in
differentially expressed genes suggested increased expression of
developmental and stress related transcription factors. Key
inferences from the transcriptomic analyses (e.g. stress, transcrip-
tion factor activation, liver injury) were supported by biochemical
and biological assays showing elevated hepatic HSP70 and mature
SREBP1 expression, and elevated liver enzymes, ALT and AST,
in plasma.
Prenatal arsenic exposure induced differential gene expression
in newborn (PND1) and 10 week old (PND70) mice. The principal
component analysis indicated that the gene expression profiles of
PND1 and PND70 livers were altered by arsenic exposure and age
indicating that the normal age-dependent changes in expression
Table 3. Gene ontology of differentially expressed microRNA target mRNAs.
Down by Arsenic PND1 (p,0.05)
Category Term Count Pvalue
KEGG_PATHWAY MMU00010:Glycolysis/Gluconeogenesis 6 0.005
Up by Arsenic PND70 (p,-0.05)
Category Term Count Pvalue
KEGG_PATHWAY MMU03060:Protein Export 4 6.76E-04
KEGG_PATHWAY MMU03010:Ribosome 6 0.022
BIOCARTA M_lectinPathway:Lectin Induced Complement Pathway 3 0.016
KEGG_PATHWAY MMU04612:Antigen Processing and Presentation 6 0.019
BIOCARTA M_classicalPathway:Classical Complement Pathway 3 0.028
KEGG_PATHWAY MMU04610:Complement and Coagulation Cascades 5 0.033
BIOCARTA m_compPathway:Complement Pathway 3 0.034
doi:10.1371/journal.pone.0038713.t003
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dysregulation of developmental program caused long lasting
changes in livers of exposed mice as indicated by identification
of HNF4A, TNF, HSPA8 (HSC70) and HSPA1B (HSP70)
identified as major hubs of interaction in differentially expressed
genes at both PND1 and PND70. The gene expression changes
associated with major hubs in the interactome analyses are
consistent with the accelerated atherogenic phenotype of arsenic
exposed mice. HNF4A (hepatocyte nuclear factor alpha) is a major
hub in the 51 gene arsenic signature as well as in both the PND1
and PND70 interactomes. HNF4A transcription factor binding
sites were enriched in the promoters of genes with arsenic-induced
differential expression at PND70 (Table 4) and PND1 differen-
tially expressed gene targets of down regulated microRNA
(Table 5). In humans, HNF4A gene variants are associated with
type 2 diabetes mellitus [31]. HNF4A plays a role in regulating the
folate receptor locus [32]. Folate receptor 2 (FOLR2) mRNA was
induced in arsenic-exposed PND70 mice (not shown). FOLR2
deficiency aggravates developmental consequences of arsenic
exposure [33], so FOLR2 induction may be a compensatory
response to arsenic exposure.
HNF4A mRNA was not changed in the microarray analyses but
several of the genes it regulates exhibited altered expression
(Table 1). These genes (lymphoid enhancer-binding factor 1 [Lef1],
glutathione S-transferase alpha 4 [Gsta4], cell division cycle
associated 5 [Cdca5], cytochrome P450 7A1 [Cyp7a1], pelota
homolog [Pelo], aquaporin 6 [Aqp6] and UDP-glucose 6-dehydro-
genase [Ugdh]) are involved in T-cell receptor regulation,
xenobiotic detoxification, cell cycle, cholesterol metabolism and
extracellular matrix biosynthesis. GSTA4, CYP1A7 and UGDH
mRNAs were decreased in PND1 livers and increased in PND70
livers. GSTA4 and CYP1A7 are xenobiotic metabolizing enzymes.
GSTA4 is involved in detoxification of lipid peroxidation products
and has been linked to atherosclerosis [34]. CYP1A7 is the rate
limiting enzyme in bile acid synthesis from cholesterol. UGDH
converts UDP-glucose to UDP-glucuronate playing a role in the
biosynthesis of glycosaminoglycans. AQP6 and LEF1 expression
changes were the reverse of GSTA4, CYP1A7 and UGDH. AQP6
and LEF1 mRNAs were increased in PND1 livers and decreased
in PND70 livers. AQP6 expression is reported to be kidney specific
[35]. Thus, elevated AQP6 mRNA expression in newborn livers is
consistent with developmental dysregulation. Lef1 is a lymphoid
enhancer binding factor expressed in pre-B and pre-T cells [36].
Its elevated expression in newborn livers suggests activation of
lymphoid cells and could contribute to an inflammatory response.
Nucleotide binding protein 1 [NUBP1] showed expression
patterns similar to AQP6 and Lef1 but is only indirectly related
Table 4. Transcription factor binding sites enriched in gene
promoters of differentially expressed mRNAs in PND70 mice.
Transcription
Factor
Number
of Genes P-Value
Enrichment
Factor
M00025[Elk-1] 97 2.46E-05 1.337
M00024[E2F] 42 6.46E-04 1.644
M00056[myogenin_/_NF-1] 56 0.001 1.371
M00341[GABP] 109 0.001 1.257
M00678[Tel-2] 59 0.002 1.389
M00652[Nrf-1] 130 0.003 1.191
M00801[CREB] 67 0.004 1.221
M00492[STAT1] 56 0.004 1.409
M00938[E2F-1] 134 0.004 1.223
M00803[E2F] 197 0.004 1.202
M00940[E2F-1] 62 0.005 1.401
M00449[Zic2] 56 0.007 1.341
M00807[EGR] 149 0.008 1.159
M00196[Sp1] 254 0.009 1.133
M00017[ATF] 96 0.01 1.276
M00531[NERF1a] 83 0.014 1.276
M00647[LXR] 77 0.014 1.319
M00373[Pax-4] 102 0.02 1.234
M01045[AP-2alphaA] 64 0.024 1.146
M00243[Egr-1] 121 0.024 1.189
M00430[E2F-1] 46 0.027 1.249
M00235[AhR:Arnt] 65 0.028 1.226
M00915[AP-2] 146 0.029 1.163
M00749[SREBP-1] 113 0.03 1.155
M00224[STAT1] 49 0.032 1.398
M01033[HNF4] 233 0.032 1.086
M00055[N-Myc] 87 0.034 1.249
M00237[AhR:Arnt] 76 0.036 1.196
M00033[p300] 53 0.038 1.26
M00695[ETF] 132 0.041 1.151
M00778[AhR] 82 0.049 1.219
A total of 690 unique entrez gene IDs are differentially expressed mRNAs at
PND70. A total 31 transcription factors are enriched for this gene set.with a P-
value ,0.05.
doi:10.1371/journal.pone.0038713.t004
Table 5. Transcription factor binding sites enriched in gene
promoters of differentially expressed mRNAs that are targets
of differentially expressed microRNAs in PND1 mice.
Transcription
Factor
Number
of Genes P-Value
Enrichment
Factor
M00649[MAZ] 28 0.003 1.72
M00490[Bach2] 17 0.004 2.2
M00731[Osf2] 13 0.006 2.304
M00467[Roaz] 12 0.007 1.779
M00976[AHRHIF] 27 0.009 1.556
M00172[AP-1] 15 0.009 1.826
M00395[HOXA3] 8 0.009 1.982
M00076[GATA-2] 13 0.021 2.012
M01033[HNF4] 47 0.022 1.176
M00678[Tel-2] 12 0.027 1.517
M00797[HIF-1] 28 0.031 1.547
M01109[SZF1-1] 14 0.031 1.59
M00652[Nrf-1] 28 0.036 1.377
M00205[GR] 11 0.04 1.743
M01045[AP-2alphaA] 18 0.042 1.731
M00484[Ncx] 12 0.042 1.859
M00378[Pax-4] 21 0.046 1.343
A total of 101 unique Entrez gene IDs are gene targets of induced or
suppressed microRNAs and appear in the gene list of differentially expressed
mRNAs at PND1. A total 17 transcription factors are enriched for this gene set
with a P-value ,0.05.
doi:10.1371/journal.pone.0038713.t005
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regulation of centrosome duplication [37] and is indirectly linked
to HSPA8 in the network. We have shown that arsenite causes
centrosome amplification similar to that induced by heat shock
[38]. PELO also is in the HNF4A transcriptional network. Similar
to HSPA8, PELO mRNA is increased in both PND1 and PND70
livers. PELO is an essential gene that has been implicated in
controlling aneuploidy [39]. Arsenic is a well established
aneuploidogen [40]. Thus, induction of both NUBP1 and PELO
may be a compensatory response to the aneuploidogenic stimulus
of arsenic. HNF4A regulates a common network of genes in liver
and pancreas that when dysregulated may contribute to develop-
ment of diabetes mellitus [41]. The incidence of diabetes mellitus
in arsenic exposed populations is elevated [42,43]. Hence, our
results suggest that the mode of action for arsenic exposure
inducing diabetes mellitus may involve its effects on the HNF4A
network in addition to the potential role of the SREBP1 network
(discussed below).
HSPA8 (HSC70) and HSPA1B (HSP70) were major hubs in the
PND1 interactome of differentially expressed mRNAs that are
targets of differentially expressed microRNAs. These genes encode
the constitutive and inducible isoforms of heat shock protein 70
(HSC70 and HSP70 respectively). HSC70 has been associated
with stabilization of newly synthesized cyclin D1 and is a
component of active cyclin D1/CDK4 holoenzyme complex
[44]. Prenatal arsenic exposure induces cyclin D1 in livers of
several strains of mice [18,45]. HSP70 induction is a well
recognized response to cellular stress induced by a wide variety
of agents. Circulating HSP70 induces a pro-inflammatory state
[46], activates macrophages [47], can serve as a cytokine for both
innate and adaptive immunity [48], and is associated with
increased risk of acute coronary syndrome [49]. Our data indicate
induced expression of HSP70 in livers of arsenic-exposed mice
(Figure 6), thus confirming the inference from the transcriptomics
data. If exported into the circulation, this enhanced HSP70
expression likely contributes to the accelerated atherogenesis
observed in arsenic exposed ApoE-knockout mice.
TNF (tumor necrosis factor alpha, TNFA) is a major hub in
both PND1 and PND70 differentially expressed mRNAs that are
targets of differentially expressed microRNAs. TNF is an
immunomodulator and stimulates the acute phase response.
TNF expression was decreased at PND1 and increased at
PND70 in arsenic exposed mice. TNF is linked to LTA (aka
TNFB) and LTB (aka TNFC) in the PND70 interactome of
differentially expressed mRNAs that are targets of differentially
expressed microRNAs. LTA and LTB are members of the tumor
necrosis factor superfamily expressed by B and T lymphocytes.
TNF, LTA and LTB are involved in regulating a wide variety of
immune responses and inflammation [50,51]. The increased
expression of this triad of inflammation mediators at PND70 is
consistent with an inflammatory response occurring in livers of
arsenic exposed PND70 mice.
Kupffer cells are the resident macrophages in the liver, are the
principal players in the innate immune system, and are a major
source of circulating cytokines including Interleukin 6 (IL6),
Interleukin 10 (IL10), TNFA and monocyte chemoattractant
protein-1 (MCP-1) [52]. Kupffer cells release MCP-1 after trauma
and this MCP-1 plays a major role in remote organ dysfunction
after trauma-hemorrhage [53]. Hepatic stellate cells are also toll-
like receptor 4 (TLR4) positive cells and secrete the inflammatory
cytokines IL6, IL8, MCP-1 and RANTES in response to LPS
[54]. Both IL6 and IL8 are linked to TNF, and also to NFKB, in
the PND70 interactome, as are LTA and LTB. IL8 attracts
neutrophils which can contribute to the liver damage; RANTES
attracts memory T-cells. Lipopolysaccharide response is mediated
by activated TLR4 which is present in both Kupffer cells and
hepatic stellate cells. TLR4 also is linked to TNF, IL6, IL8 and
NFKB in the interactome (Figure S2). Thus, both these cell
populations may contribute to circulating levels of cytokines that
contribute to activation of monocytes in the initiation of
atherogenesis. We have shown that chronic arsenic exposure for
12 weeks in adult mice elevates plasma MCP-1 and IL6 [55], both
cytokines that are associated with atherosclerosis.
Analysis of TFBS in promoters of genes differentially expressed
in 10 week old mice exposed to arsenic in utero revealed a number
Figure 5. Cluster maps of enriched transcription factor binding sites (TFBS) in promoters of genes that are differentially expressed
at PND1 (101 genes) and PND70 (135 genes) and also are targets of differentially expressed microRNAs at PND1 (Table S6) and
PND70 (Table S11) respectively.
doi:10.1371/journal.pone.0038713.g005
Figure 6. HSP70 and SREBP1 expression in livers of 10 week
old mice. A. Western blot analysis of HSP70 and SREBP1. The SREBP1
fragment shown is the 68 kDa cleavage fragment. B. Densitometric
quantitation of western blots. Signals for each protein were normalized
to GAPDH and mean of controls (#’s 1–4) was set=1. Representative of
triplicate blots shown. *=p,0.05.
doi:10.1371/journal.pone.0038713.g006
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regulated by the associated transcription factors. Stress response
factors HSF1, NFKB and AP1 were among the transcription
factors with binding sites enriched in the differentially expressed
PND1 mRNAs. AP1 and NFKB were linked in a subset of 12
genes that IPA associated with inflammatory diseases including
rheumatic disease and diabetes mellitus (not shown). Fry et al
observed a network of genes with differential expression integrat-
ing NFKB in cord blood leukocytes of infants exposed to high
levels of arsenic in utero [56]. This network included a sub-network
centered around the pro-inflammatory interleukin I family
member IL1B. We saw that IL18, an inflammatory cytokine
structurally similar to IL1B, was a major hub in the interactome in
our arsenic exposed PND1 mice (Figure 4A). Arsenite exposure
induces HSP70 expression via activation of HSF1 [57]. Our
microarray data indicate that HSP70 mRNA is induced and that a
network of genes with HSF1 binding sites in their promoters is
differentially expressed at both PND1 and PND70. Thus, the
inferences made from the TFBS analyses are consistent with
observations made by others both in humans and in vitro.
The TFBS analysis also showed that approximately 1/6 of the
genes differentially expressed at PND70 had SREBP1 binding
sites. This observation suggested that SREBP1 might be activated
in the livers of arsenic exposed mice and we confirmed elevated
levels of activated SREBP1 by western blot analyses. Thus, the
power of the genomics approach to elucidate potential mecha-
nisms is clearly exemplified by the biochemical confirmation of
activated SREBP1 induction. Further study of the other inferred
activated transcription factors is needed to gain a more complete
understanding of the long lasting effect of the prenatal arsenic
exposure on gene expression and liver development.
SREBP1 has important functions in regulating cholesterol and
triglyceride synthesis, adipogenesis and insulin action [58]. Insulin
induces SREBP1 in liver and adipocytes [59–61]. SREBP1 is
responsive to insulin and glucose stimulation and regulates a
plethora of genes in human HepG2 cells [62]. SREBP1 expression
is reduced in human adipocytes and skeletal muscle in obese and
insulin resistant people but can be returned to normal by
hyperinsulinemia [63]. Hence, SREBP1 is intimately involved in
lipid metabolism and is dysregulated in diabetic and pre-diabetic
patients, both conditions linked to elevated CVD incidence. Our
analysis revealed that SREBP1 likely also regulates a battery of
genes not involved with lipid biosynthesis and not previously
known to be SREBP1 regulated genes. Analysis of this set of genes
revealed linkages to inter-related disease processes rheumatoid
arthritis and insulin dependent diabetes mellitus. Both of these
inflammatory diseases are associated with accelerated atheroscle-
rosis [64]. Rheumatoid arthritis is the paradigm of a chronic
systemic inflammatory disease. Rheumatoid arthritis patients
exhibit greatly increased incidence of CVD [65]. Metabolic
syndrome, a consequence of complex interactions between liver
and adipose tissue, is well established as a risk factor for
atherosclerosis leading to cardiovascular diseases. Metabolic
syndrome has been proposed to provide linkage between
rheumatoid arthritis and CVD [66]. The observed relationship
of diabetes mellitus genes and rheumatoid arthritis genes supports
an earlier suggestion that these disorders are linked [67]. Increased
risk of CVD is a well established consequence of diabetes mellitus
[68]. Our results suggest a role for activated SREBP1 in the
etiology of these chronic systemic inflammatory diseases. This
systemic inflammation likely contributes to the accelerated
atherogenic phenotype of the prenatal arsenic exposed ApoE-
knockout mice. Thus, the complex nature of the interactions
between systemic inflammation and atherogenesis are reflected in
Figure 7. Analysis of SREBP1 gene network for disease functions.
doi:10.1371/journal.pone.0038713.g007
Figure 8. Plasma ALT and AST in arsenic-exposed and -
unexposed PND70 ApoE-knockout mice. Mean6S.E. n=829
(*p,0.026; #p=0.056).
doi:10.1371/journal.pone.0038713.g008
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SREBP1 occupancy of the promoters in these genes in future
studies.
Endoplasmic reticulum (ER) stress causes dysregulation of the
cholesterol and triglyceride synthesis pathways by activating
SREBP1 [69]. Arsenic induces ER stress in a variety of tissues
and cell types [70–74]. Thus, induction of ER stress in liver by
arsenic exposure would be expected. Our data suggest that the ER
stress is induced in the livers long after the prenatal arsenic
exposure has ended. This post-exposure response is consistent with
an alteration in developmental program of the liver resulting in
either a persistent induction of ER stress or priming for later
induction by a second agent such as the hyperlipidemia that
develops in these mice as they age. The common embryonic
lineage of liver and pancreas suggests that the prenatal arsenic
exposure may have similar effects in pancreatic cells. Thus, study
of these events in pancreatic beta cells may provide important
information regarding the linkage between arsenic exposure and
diabetes mellitus.
In summary, our results clearly indicate that the prenatal arsenic
exposurehasdysregulatedthedevelopmentalprogramoftheliveras
reflected in the gene expression profile differences. The gene
expression changes with no obvious signs of liver inflammation
suggest a pro-inflammatory state. We speculate that this pro-
inflammatory state is the first hit in a two hit process leading to
chronic low grade inflammation in the liver. The resulting liver
disease likely provides the source of inflammation that triggers
accelerated and exacerbated atherosclerosis in ApoE
2/2 mice
prenatally exposed to arsenic. Our published studies of livers of
C57Bl/6 mice chronically exposed to arsenic also found little
histologicalevidenceofliverinjuryinunchallengedmice[75].Itwas
only after challenge with lipopolysaccharide (LPS) that we observed
dramatic evidence of a hyper-response in the livers of arsenic-
exposed mice. Thus, it is not surprising that there is no apparent
histological difference in the livers of these unchallenged mice after
transplacental arsenic exposure. The gene expression studies show
linkages to chronic systemic inflammatory diseases, rheumatoid
arthritis and diabetes mellitus. Both of these disease processes
contribute toincreasedatherogenesis.Weidentifiedapotentialnew
role for SREBP1 in regulating genes associated with these chronic
systemic inflammatory diseases. SREBP1 is activated by ER stress
suggesting that SREBP1 may be a common mediator of systemic
inflammation for agents that induce ER stress. In order to
understand the mechanism of altered development leading to
accelerated atherogenesis, it will be important to compare gene
expressionprofilesatmultipleagesfromfetalstagetoadulthoodand
to confirm the role of SREBP1 in the initiation of systemic
inflammation.
Materials and Methods
Ethics Statement
All procedures were performed in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health under
protocols 03151 and 06093 approved by the University of
Louisville Institutional Animal Care and Use Committee.
Mice and Exposure Protocols
Apolipoprotein E-knockout mice (strain B6.129P2-Apoe
tm1Unc/
J) were purchased from Jackson Laboratories and maintained in
an AALAAC approved vivarium as previously described [21].
Mice were bred by housing two females with a male. Females were
checked daily for the presence of a vaginal plug which was
designated gestational day 0 (GD0). Plug-positive females were
caged separately until weaning at postnatal day (PND) 21. Dams
were provided drinking water containing 85 mg/L sodium
arsenite (49 ppm As) ad libitum from GD8 through birth. Arsenic
containing water was changed twice weekly. After birth, dams
were provided normal tap water ad libitum. Adult mice (10 weeks
old, PND70) were euthanized by CO2 asphyxiation and newborns
(PND1) by decapitation. Livers were quickly excised and snap
frozen in liquid nitrogen.
Measurement of Liver Arsenic Levels
Pregnant dams and fetuses were euthanized on GD18 by CO2
asphyxiation and decapitation, respectively. Livers were excised
quickly and snap frozen. Three dams were included in each
maternal group, and one male fetus from each of the pregnant
dams was included in the fetal group. Small samples of frozen
maternal and GD18 fetal livers (300–600 mg) were transferred to
2 mL acid washed (0.1 M HNO3 acid) centrifuge tubes and
digested in 350 mL concentrated nitric acid overnight. One
hundred mL of digested sample was transferred to 10 mL acid
washed microwavable digestion tubes in triplicates, and every 3
rd
sample from each group was spiked with 5 ng arsenic standards
(SPEX CertiPrep, Metuchen, NJ). The samples were microwave
digested at 150uC for 10 min using Automated Microwave
Synthesis Workstation. Residues were removed by centrifugation,
and 1.9 mL of 18 mega-ohm water containing 10 ppb internal
standard solution was added in to every sample to give 5% HNO3
acid. Each sample (1.5 mL) was transferred to acid washed
polypropylene deep-well 96 well plates for ICP-MS analysis using
Thermo Electron ICP-MS, X-Series (in the Center for Regulatory,
Environmental and Analytical Metabolomics at University of
Louisville). Blank was concentrated nitric acid. Results are
expressed in ng arsenic/g wet weight liver.
RNA Preparation, Probe Preparations and Microarrays
Using mirVANA RNA purification kits (Ambion, Carlsbad,
CA), total RNAs were purified from samples of frozen livers from
three newborn (PND1) and three 10-week old mice (PND70) that
had been exposed or unexposed to arsenic in utero. Each mouse was
from a separate litter. RNA was quantitated and integrity
determined on a Nanochip using a Bioanalyzer (Agilent, Santa
Clara, CA). Microarray analyses for microRNA abundance in
total liver RNA was performed by Exiqon (Woburn, MA) using
Exiqon LNA 1500 microarrays in a two-color design against
mouse standard total RNA (Ambion, now part of Applied
Biosystems). Microarray analyses for mRNA abundance was
performed using 2 color design against mouse standard total RNA
(Stratgene, LaJolla, CA) on NIA Mouse 44K Microarray v2.1
(Whole Genome 60-mer Oligo: Agilent #2514117 [76]). Probe
preparation, hybridization, scanning of arrays and log2 normal-
ization of data were as described [76].
Microarray Data Analyses
Microarray data were mean-centered and quantile normalized
to normalize gene expression distribution across the samples. The
ratiometric values (test/reference) were then transformed to log2
and lowess smoothing. The data were then subjected to two-way
ANOVA (treatment, developmental time at p,0.01) for changes
induced by arsenic exposure in PND1 and PND70 mice using
Partek Genomics Suite v 6.3 (http://www.partek.com/). There
were 763 significant probes corresponding to 712 genes with
significant expression changes for PND70 samples and 848 probes
corresponding to 797 genes for PND1 samples in the mRNA
microarray dataset. The intersection of these two gene sets yielded
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Unsupervised hierarchical clustering and principal component
analysis were performed using Partek software. Gene ontology
annotation (Tables S1, S2, S3, S4) was performed using DAVID
[77,78] and interaction networks based on published literature
were prepared using Partek. Enriched transcription factor binding
sites were detected using the Expander 4.1 software [79,80]. In
order to detect enrichment, the background gene set was chosen
from the total gene list downloaded from GEO [81] for NIA
Mouse 44K Microarray V2.1 (Whole Genome 60-mer Oligo;
accession GPL2552). Additional analyses of disease functions were
performed using Ingenuity Pathway Analysis software. Microarray
data have been deposited in the NCBI Gene Expression Omnibus
Series record GSE30783 and are in compliance with MIAME
guidelines.
Identification of miRNA Targets
Gene targets of differentially expressed miRNAs were detected
using Mus musculus miRBase v5, which lists the targets in terms of
Ensembl transcripts. Ensembl gene transcripts and corresponding
gene identifiers were downloaded from BioMart using Ensembl 52
and Mus musculus genes NCBIM37. All miRNA targets were then
converted to Ensembl gene identifiers which could then be directly
compared to the resulting differentially expressed mRNA.
Detection of Enriched Transcription Factors
Enriched transcription factors were detected using the Expand-
er 4.1 software [82,83]. For each of the subsets, the Entrez gene
identifiers were uploaded as a gene set. These gene sets were
analyzed for transcription factor enrichment using the PRIMA
software tool within Expander. In order to detect enrichment, the
background gene set was chosen from the total gene list
downloaded from GEO [84] for NIA Mouse 44K Microarray
V2.1 (Whole Genome 60-mer Oligo; accession GPL2552).
A list of the transcription factors significantly enriched given the
corresponding gene sets, as well as the number of genes within the
set regulated by those transcription factors along with the P-Value
(cutoff of 0.05) and enrichment factor are reported.
Plasma Liver Enzyme Assay
Blood was drawn by cardiac puncture of anesthetized mice into
collection tubes for preparation of plasma. Sodium citrate was
used as an anticoagulant. Plasma levels of alanine aminotransfer-
ase (ALT) and aspartate aminotransferase (AST) were measured
using commercially available kits (Infinity Liquid Reagents,
Thermo Electron Corporation, Pittsburgh, PA).
Western Blot Analysis of Liver Proteins
Liver samples obtained from mice derived from 7 different
litters were homogenized in lysis buffer [10 mM Tris-HCl pH 7.4,
1 mM EDTA, 0.1% (w/v) SDS, 1 mM phenylmethylsulphonyl-
fluoride (PMSF)] for protein isolation. Protein concentrations were
determined by bicinchoninic acid (BCA) protein assay (Thermo
Scientific, Rockford, IL.). Proteins were separated by SDS-PAGE
(12% acrylamide), electroblotted to nitrocellulose, and probed with
antibodies to HSC70 (rat mAb, 1:1000, Assay Designs/Stressgen,
Plymouth Meeting, PA.), HSP70i (mouse mAb, 1:10,000, Assay
Designs/Stressgen, Plymouth Meeting, PA), SREBP1 (rabbit
mAb, 1:1000; Abcam, Cambridge, MA), and their corresponding
secondary antibodies (anti-rat, anti-mouse and anti-rabbit) conju-
gated to horseradish peroxidase (HRP). The signals were detected
using chemiluminescence (ECL) substrate (Pierce, Rockford, IL)
and exposure to Kodak XAR x-ray film. Quantification was
performed with Image Quant software.
Supporting Information
Figure S1 Interactome of mRNAs suppressed in livers of
PND70 mice exposed to arsenic prenatal. Major hubs include
HNF4A, IL8 and calcium signaling.
(TIF)
Figure S2 Interactome of mRNAs induced in livers of arsenic
exposed PND70 mice. Major hubs include NFKB1, TNF, IL6 and
IL8. Minor hubs include TLR4, LTB, LTA, CHUK, IL1A,
HSPA1B and HSPA8.
(TIF)
Table S1 GO annotation analysis of the mRNAs with
expression induced in PND1 livers of in utero arsenic exposed
mice were analyzed by DAVID to identify which pathways were
represented.
(DOCX)
Table S2 GO annotation analysis of the mRNAs with
expression suppressed in PND1 livers of in utero arsenic exposed
mice were analyzed by DAVID to identify which pathways were
represented.
(DOCX)
Table S3 GO annotation analysis of the mRNAs with
expression induced in PND70 livers of in utero arsenic exposed
mice were analyzed by DAVID to identify which pathways were
represented.
(DOCX)
Table S4 GO annotation analysis of the mRNAs with
expression suppressed in PND70 livers of in utero arsenic exposed
mice were analyzed by DAVID to identify which pathways were
represented.
(DOCX)
Table S5 Gene promoters of differentially expressed mRNAs
that are targets of microRNAs suppressed in arsenic exposed
PND1 mice were analyzed for transcription factor binding sites. A
total of 64 unique Entrez gene IDs are gene targets of down
regulated microRNA and appear in the gene list of differentially
expressed mRNAs at PND1. A total 15 transcription factors are
enriched for this gene set with a P-value ,0.05.
(DOCX)
Table S6 Gene promoters of differentially expressed mRNAs
that are targets of microRNAs either induced or suppressed in
arsenic exposed PND1 mice were analyzed for transcription factor
binding sites. A total of 101 unique Entrez gene IDs are gene
targets of up or down regulated microRNA and appear in the gene
list of differentially expressed mRNAs at PND1. A total 17
transcription factors are enriched for this gene set with a P-value
,0.05.
(DOCX)
Table S7 Gene promoters of differentially expressed mRNAs
that are targets of microRNAs both induced and suppressed in
arsenic exposed PND1 mice were analyzed for transcription factor
binding sites. A total of 12 unique Entrez gene IDs are gene targets
of both up AND down regulated microRNA and appear in the
gene list of differentially expressed mRNAs at PND1. A total 11
transcription factors are enriched for this gene set with a P-value
,0.05.
(DOCX)
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that are targets of microRNAs induced in arsenic exposed PND1
mice were analyzed for transcription factor binding sites. A total of
49 unique Entrez gene IDs are gene targets of up regulated
microRNA and appear in the gene list of differentially expressed
mRNAs at PND1. A total 10 transcription factors are enriched for
this gene set with a P-value ,0.05.
(DOCX)
Table S9 Gene promoters of differentially expressed mRNAs
that are targets of microRNAs induced in arsenic exposed PND70
mice were analyzed for transcription factor binding sites. A total of
33 unique Entrez gene IDs are gene targets of up regulated
microRNA and appear in the gene list of differentially expressed
mRNAs at PND70. A total 13 transcription factors are enriched
for this gene set with a P-value ,0.05.
(DOCX)
Table S10 Gene promoters of differentially expressed mRNAs
that are targets of microRNAs suppressed in arsenic exposed
PND70 mice were analyzed for transcription factor binding sites.
A total of 124 unique entrez gene IDs are gene targets of down
regulated miRNA and appear in the gene list of differentially
expressed mRNAs at PND70. A total 21 transcription factors are
enriched for this gene set.with a P-value ,0.05.
(DOCX)
Table S11 Gene promoters of differentially expressed mRNAs
that are targets of microRNAs either induced or suppressed in
arsenic exposed PND70 mice were analyzed for transcription
factor binding sites. A total of 135 unique entrez gene IDs are gene
targets of up OR down regulated miRNA and appear in the gene
list of differentially expressed mRNAs at PND70. A total 28
transcription factors are enriched for this gene set.with a P-value
,0.05.
(DOCX)
Table S12 Gene promoters of differentially expressed mRNAs
that are targets of microRNAs both induced and suppressed in
arsenic exposed PND70 mice were analyzed for transcription
factor binding sites. A total of 22 unique entrez gene IDs are gene
targets of BOTH up AND down regulated miRNA and appear in
the gene list of differentially expressed mRNAs at PND70. A total
9 transcription factors are enriched for this gene set.with a P-value
,0.05.
(DOCX)
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